EDITORIAL
Published on 20 Feb 2023
Editorial: Biology and treatment of high-risk CLL
doi 10.3389/fonc.2022.1109950
- 1,483 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Biology and Treatment of High-Risk CLL
Biology and Treatment of High-Risk CLL
16k
Total downloads
64k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
OPINION
Published on 09 Feb 2023
Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?
doi 10.3389/fonc.2023.1106579
- 4,304 views
- 1 citation
MINI REVIEW
Published on 13 Oct 2022
NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia
doi 10.3389/fonc.2022.1019730
- 3,409 views
- 2 citations
BRIEF RESEARCH REPORT
Published on 28 Jun 2022
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study
doi 10.3389/fonc.2022.909615
- 4,275 views
- 5 citations
ORIGINAL RESEARCH
Published on 24 Jun 2022
Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
doi 10.3389/fonc.2022.859618
- 1,824 views
- 1 citation
MINI REVIEW
Published on 28 Apr 2022
Cellular Therapy in High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter Syndrome
doi 10.3389/fonc.2022.888109
- 3,451 views
- 5 citations
REVIEW
Published on 22 Mar 2022
Biology and Treatment of Richter Transformation
doi 10.3389/fonc.2022.829983
- 12,786 views
- 35 citations
REVIEW
Published on 16 Feb 2022
Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases
doi 10.3389/fonc.2022.808886
- 2,545 views
- 11 citations
MINI REVIEW
Published on 08 Feb 2022
Impact of Low-Burden TP53 Mutations in the Management of CLL
doi 10.3389/fonc.2022.841630
- 3,248 views
- 4 citations
MINI REVIEW
Published on 13 Jan 2022
“Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes
doi 10.3389/fonc.2021.826245
- 2,410 views
- 6 citations
PERSPECTIVE
Published on 21 Dec 2021
The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia
doi 10.3389/fonc.2021.771669
- 1,650 views
- 2 citations
REVIEW
Published on 16 Dec 2021
Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective
doi 10.3389/fonc.2021.790004
- 7,410 views
- 13 citations
Published in
Frontiers in Oncology
- Hematologic Malignancies
Impact
- 64kTopic views
- 45kArticle views
- 16kArticle downloads